"On December 21, 2015, Imprimis Pharmaceuticals, Inc. (the “Company”) entered into a Commission Agreement (the “PCCA Commission Agreement) with Professional Compounding Centers of America, Inc. (“PCCA”). The PCCA Commission Agreement replaces a Strategic Alliance Agreement (the “PCCA Strategic Alliance Agreement”) entered into on February 18, 2013 and a License Agreement (the “PCCA License Agreement) entered into on August 30, 2012, in each case between the Company and PCCA."

On December 21, 2015, Imprimis Pharmaceuticals, Inc. (the “Company”) entered into a Commission Agreement (the “PCCA Commission Agreement) with Professional Compounding Centers of America, Inc. (“PCCA”). The PCCA Commission Agreement replaces a Strategic Alliance Agreement (the “PCCA Strategic Alliance Agreement”) entered into on February 18, 2013 and a License Agreement (the “PCCA License Agreement) entered into on August 30, 2012, in each case between the Company and PCCA. Upon the execution of the PCCA Commission Agreement, the Company and PCCA mutually agreed to terminate the PCCA Strategic Alliance Agreement and PCCA License Agreement.

read more at: http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=11080840-1081-7382&type=sect&TabIndex=2&dcn=0001493152-15-006428&nav=1&src=Yahoo